| Issue |
Section |
Title |
File |
| Vol 27, No 4 (2020) |
Articles |
Modern topical treatment of psoriasis in diabetic patients |
|
| Vol 27, No 12 (2020) |
Articles |
Clinical features of skin lesions in patients with diabetes mellitus |
|
| Vol 28, No 4 (2021) |
Articles |
Optimization of the diabetes screening questionnaire for patients with psoriasis |
|
| Vol 28, No 8 (2021) |
Articles |
Analysis of comorbid conditions and tolerability of treatment with genetically engineered biological drugs and methotrexate in patients with psoriasis |
|
| Vol 28, No 8 (2021) |
Articles |
Epi-Oral F199 - systemic anti-age therapy and antioxidant protection: ingredients |
|
| Vol 28, No 8 (2021) |
Articles |
Longitudinal systemic therapy of plaque psoriasis: a literature review with a case report of use of ixekizumab |
|
| Vol 28, No 8 (2021) |
Articles |
Review of clinical trials of the IL-23 inhibitor guselkumab. Experience of using genetically engineered biological therapy with guselkumab in a patient with severe arthropathic psoriasis |
|
| Vol 28, No 8 (2021) |
Articles |
Injection bioreparation is a promising direction in the treatment of involutional skin changes |
|
| Vol 28, No 8 (2021) |
Articles |
A universal injectable preparation for the correction of cosmetological and dermatological skin problems |
|
| Vol 28, No 8 (2021) |
Articles |
An innovative injection method for correcting excess adipose tissue in the face, submental area and neck |
|
| Vol 29, No 4 (2022) |
Articles |
Application of the diabetes screening questionnaire in patients with psoriasis |
|
| Vol 29, No 8 (2022) |
Articles |
Modern concepts of autophagy in the concept of premature aging |
|
| Vol 29, No 8 (2022) |
Articles |
Combined protocols for the correction of unwanted hyperpigmentation in cosmetic patients |
|
| Vol 30, No 8 (2023) |
Original articles |
Modern possibilities for correcting the uric acid level and eliminating skin manifestations of gout |
|
| Vol 30, No 8 (2023) |
Original articles |
Amino acid replacement therapy as preparation and enhancement of the effectiveness of collagen-stimulating methods |
|
| Vol 30, No 8 (2023) |
Original articles |
The prevalence of phakomatoses in Western Siberia |
|
| Vol 30, No 8 (2023) |
Clinical case |
A clinical case of the use of the selective janus kinase inhibitor upadacitinib in an adult patient with severe atopic dermatitis |
|
| Vol 30, No 8 (2023) |
Clinical case |
Case report: successful treatment of pustular plantar psoriasis with an interleukin-17A inhibitor, netakimab |
|
| Vol 30, No 14 (2023) |
Dermatology/allergology |
Seborrheic dermatitis. association of MCM6 lactase gene polymorphism and seborrheic dermatitis by the example of a clinical case |
|
| Vol 32, No 5 (2025) |
Clinical experience |
Physiotherapeutic approach in the treatment of rosacea. Modern approaches to the treatment of rosacea through the prism of pathogenesis |
|
| Vol 32, No 5 (2025) |
Original articles |
Bite pathology in patients with signs of undifferentiated connective tissue dysplasia (UCTD). Possibilities of aesthetic correction of changes in the lower third of the face in patients with UCTD after orthodontic treatment |
|
| Vol 32, No 5 (2025) |
Original articles |
Possibilities of presarcopenia and sarcopenia prevention in the face using synchronized radiofrequency technology and High-Intensity Facial Electrical Stimulation (HIFES) |
|
| Vol 32, No 5 (2025) |
Original articles |
Study of the effect of equine type I collagen preparation on the process of collagenesis in an experimental model using gene expression measurements and histological assessment of tissues |
|
| Vol 32, No 5 (2025) |
Clinical case |
Current concepts of hidradenitis suppurativa. Experience with interleukin-17 inhibitor in a patient with severe hidradenitis suppurativa |
|
| Vol 32, No 5 (2025) |
Clinical case |
Psoriasis of special localizations. Experience with the use of the interleukin-17A inhibitor netakimab for the treatment of psoriasis of special localizations |
|
